Rising Creatinine and BK Viremia After Kidney Transplant: Lower or Increase Immunosuppression?
Ms. K is a 46-year-old woman 9 months after deceased-donor kidney transplant. Her baseline creatinine was 1.3 mg/dL; today it is 1.9 mg/dL, up from 1.4 mg/dL three weeks ago. She feels well, has no fever, dysuria, or graft tenderness. Medications: tacrolimus 3 mg twice daily (trough 7.8 ng/mL), mycophenolate 500 mg twice daily, prednisone 5 mg daily, trimethoprim-sulfamethoxazole 80/400 mg daily. Urinalysis shows 1+ protein, no blood, no leukocyte esterase; urine culture negative. BK virus plasma PCR is 12,000 copies/mL; CMV IgG positive, CMV PCR negative. Donor-specific antibodies are negative. She had one episode of treated acute rejection 4 months ago. She asks whether her immunosuppression should be increased because her creatinine is rising.
1. How do you interpret the BK viral load and creatinine rise, and what is the next diagnostic step?
Read the worked answer
A BK plasma viral load of 12,000 copies/mL with a rising creatinine and no other explanation is concerning for BK virus nephropathy, but viremia alone is not diagnostic. BK nephropathy is a tissue diagnosis, and BK can coexist with acute rejection. Her bland urinalysis and negative DSA do not exclude either process. The next step is a kidney biopsy with SV40 staining and concurrent evaluation for rejection, including C4d and donor-specific antibody assessment. Repeat BK PCR and obtain urine BK PCR to confirm the trend. Increasing immunosuppression now would be dangerous if BK nephropathy is present because it could worsen viral injury.
2. Should immunosuppression be reduced, and how? What are the risks of your plan?
Read the worked answer
Yes-reduction of immunosuppression is first-line therapy for BK nephropathy. I would coordinate with the transplant team and reduce the calcineurin inhibitor and/or antimetabolite stepwise, often by about 25–50%, with a lower tacrolimus target than the current trough. Because she had treated rejection 4 months ago, I would not stop all immunosuppression abruptly; I would reduce in a planned way and monitor closely. The main risk is precipitating acute rejection. There is no routine role for empiric fluoroquinolones or cidofovir; those are reserved for refractory cases.
3. What monitoring schedule and safety parameters would you set for the next 4–8 weeks?
Read the worked answer
Check creatinine and BK plasma PCR every 1–2 weeks until the viral load is clearly declining, then space testing. Monitor tacrolimus troughs, CBC for mycophenolate toxicity, urinalysis, and CMV PCR because immunosuppression changes can permit reactivation. Check donor-specific antibodies and consider repeat biopsy if creatinine continues to rise or the BK load does not fall. If BK persists with graft dysfunction despite reduced immunosuppression, reevaluate for refractory BK nephropathy versus rejection. Educate her to avoid nephrotoxins and to report fever, graft pain, or decreased urine output.